You are here
- Home
- Therapy Areas
- Cardiovascular
NIS “Screening epidemiological program on compensation evaluation of DM type 2 patients on OAD monotherapy and physicians satisfaction of their usage”
- Disease
- diabetes type 2
- Drug Name
- Onglyza
- Generic Name
- Saxagliptin
- Sponsor
- AstraZeneca
- Drug Status
- Approved Medicine
- Phase
- Non-Interventional Study
- Start Date
- Dec 8, 2010
- Study Name
- NIS-CRU-ONG-2010/1
- Study Id
- NIS-CRU-ONG-2010/1
- ClinicalTrials.gov ID
- NCT01275794
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report
-
Feb 24, 2012
